Regeneron Pharmaceuticals (REGN) Short Interest Ratio & Short Volume → Biden replacement revealed? (From Paradigm Press) (Ad) Free REGN Stock Alerts $966.49 -6.67 (-0.69%) (As of 05:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals Short Interest DataCurrent Short Interest1,630,000 sharesPrevious Short Interest1,570,000 sharesChange Vs. Previous Month+3.82%Dollar Volume Sold Short$1.59 billionShort Interest Ratio3.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares110,190,000 sharesPercentage of Shares Shorted1.48%Today's Trading Volume345,884 sharesAverage Trading Volume475,347 sharesToday's Volume Vs. Average73% Short Selling Regeneron Pharmaceuticals ? Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartREGN Short Interest Over TimeREGN Days to Cover Over TimeREGN Percentage of Float Shorted Over Time Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. Regeneron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,630,000 shares $1.59 billion +3.8%N/A3.7 $978.21 4/30/20241,570,000 shares $1.40 billion +13.0%N/A3.4 $890.66 4/15/20241,390,000 shares $1.25 billion -2.1%N/A3 $898.56 3/31/20241,420,000 shares $1.37 billion +2.2%N/A3 $962.49 3/15/20241,390,000 shares $1.34 billion +2.2%N/A2.7 $964.47 2/29/20241,360,000 shares $1.31 billion -0.7%N/A2.4 $966.09 Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,370,000 shares $1.31 billion +9.6%N/A2.4 $954.73 1/31/20241,250,000 shares $1.18 billion +16.8%N/A2.2 $942.78 1/15/20241,070,000 shares $998.52 million +0.9%1.0%1.9 $933.20 12/31/20231,060,000 shares $930.99 million -13.1%1.0%2 $878.29 12/15/20231,220,000 shares $1.05 billion -0.8%1.2%2.4 $859.14 11/30/20231,230,000 shares $1.01 billion -12.1%1.2%2.7 $823.81 11/15/20231,400,000 shares $1.11 billion +6.9%1.3%3.3 $792.38 10/31/20231,310,000 shares $1.02 billion -4.4%1.3%3 $779.89 10/15/20231,370,000 shares $1.15 billion +16.1%1.3%3 $839.63 9/30/20231,180,000 shares $971.09 million -18.6%1.1%2.4 $822.96 9/15/20231,450,000 shares $1.19 billion -2.0%1.4%2.5 $823.40 8/31/20231,480,000 shares $1.22 billion +8.8%1.4%2.5 $826.49 8/15/20231,360,000 shares $1.10 billion +1.5%1.3%2.1 $805.91 7/31/20231,340,000 shares $994.16 million +5.5%1.3%2.1 $741.91 7/15/20231,270,000 shares $912.52 million +17.6%N/A2 $718.52 6/30/20231,080,000 shares $776.02 million -12.2%N/A1.8 $718.54 6/15/20231,230,000 shares $963.18 million +7.9%N/A2.2 $783.07 5/31/20231,140,000 shares $838.54 million -5.8%N/A2 $735.56 5/15/20231,210,000 shares $908.66 million +2.5%N/A2.1 $750.96 4/30/20231,180,000 shares $946.11 million -2.5%1.1%2 $801.79 4/15/20231,210,000 shares $1.00 billion -6.9%1.2%2 $829.33 3/31/20231,300,000 shares $1.07 billion +7.4%1.2%2 $821.67 3/15/20231,210,000 shares $919.96 million +0.8%1.2%1.9 $760.30 2/28/20231,200,000 shares $912.50 million -10.5%1.2%1.9 $760.42 2/15/20231,340,000 shares $1.01 billion -8.2%1.3%2.1 $752.40 1/31/20231,460,000 shares $1.11 billion +3.6%1.4%2.2 $758.47 1/15/20231,410,000 shares $1.02 billion -6.0%1.4%2.2 $722.13 12/30/20221,500,000 shares $1.08 billion +4.2%1.5%2.2 $721.49 12/15/20221,440,000 shares $1.05 billion -7.1%1.4%2.1 $731.27 11/30/20221,550,000 shares $1.17 billion -11.9%1.5%2.1 $751.70 11/15/20221,760,000 shares $1.28 billion -0.6%1.7%2.3 $728.73 10/31/20221,770,000 shares $1.33 billion -16.1%1.7%2.3 $748.75 10/15/20222,110,000 shares $1.55 billion -7.5%2.1%2.8 $736.06 9/30/20222,280,000 shares $1.57 billion -3.8%2.2%3.2 $688.87Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report 9/15/20222,370,000 shares $1.67 billion -18.6%2.3%3.5 $705.85 8/31/20222,910,000 shares $1.69 billion -0.7%2.8%4.3 $581.06 8/15/20222,930,000 shares $1.88 billion -4.6%2.9%4.6 $643.29 7/31/20223,070,000 shares $1.79 billion +7.3%3.0%4.6 $581.69 7/15/20222,860,000 shares $1.74 billion +3.3%2.8%4.3 $607.54 6/30/20222,770,000 shares $1.64 billion +7.4%N/A4.1 $591.13 6/15/20222,580,000 shares $1.45 billion +23.4%N/A3.7 $561.19 5/31/20222,090,000 shares $1.39 billion -4.1%N/A3.1 $664.74 5/15/20222,180,000 shares $1.41 billion +0.9%N/A3.4 $645.52 4/30/20222,160,000 shares $1.42 billion +0.5%N/A3.2 $659.11 4/15/20222,150,000 shares $1.58 billion -2.3%2.1%3 $733.02 3/31/20222,200,000 shares $1.54 billion -8.0%2.1%3 $698.42 3/15/20222,390,000 shares $1.59 billion +6.7%2.3%3.3 $665.93 2/28/20222,240,000 shares $1.39 billion +4.7%2.2%3 $618.36 2/15/20222,140,000 shares $1.35 billion +19.6%2.1%2.8 $630.15 1/31/20221,790,000 shares $1.09 billion -1.7%1.7%2.4 $608.59 1/15/20221,820,000 shares $1.12 billion +11.0%1.8%2.4 $615.24 12/31/20211,640,000 shares $1.04 billion +7.2%1.6%2.2 $631.52 12/15/20211,530,000 shares $1.01 billion +3.4%1.5%1.9 $657.93 11/30/20211,480,000 shares $942.06 million -8.1%1.4%2 $636.53 11/15/20211,610,000 shares $1.04 billion -14.4%1.6%2.1 $647.73 10/29/20211,880,000 shares $1.20 billion +6.8%1.8%2.3 $639.94 10/15/20211,760,000 shares $973.70 million -2.2%1.7%2.2 $553.24 9/30/20211,800,000 shares $1.09 billion +14.7%1.8%2.4 $605.18 9/15/20211,570,000 shares $1.02 billion +15.4%1.5%2 $652.00 8/31/20211,360,000 shares $915.82 million -3.6%1.3%1.7 $673.40 8/13/20211,410,000 shares $880.95 million -11.3%1.4%1.8 $624.79 7/30/20211,590,000 shares $913.63 million -13.6%1.6%2.1 $574.61 7/15/20211,840,000 shares $1.08 billion +30.5%1.8%2.4 $589.32 6/30/20211,410,000 shares $787.54 million -26.6%1.4%1.8 $558.54 6/15/20211,920,000 shares $1.01 billion -9.0%1.9%2.4 $527.49 5/28/20212,110,000 shares $1.06 billion -5.4%2.1%2.6 $502.43 5/14/20212,230,000 shares $1.15 billion -4.7%2.2%2.6 $517.17 4/30/20212,340,000 shares $1.13 billion -14.9%2.3%2.5 $485.00 4/15/20212,750,000 shares $1.32 billion +24.4%2.7%2.8 $481.16 3/31/20212,210,000 shares $1.04 billion -16.9%2.2%2.1 $470.67 3/15/20212,660,000 shares $1.25 billion +14.7%2.6%2.6 $471.46 2/26/20212,320,000 shares $1.05 billion +10.0%2.3%2.2 $453.19 2/12/20212,110,000 shares $1.04 billion +8.8%2.1%2 $490.54 1/29/20211,940,000 shares $982.16 million -18.8%1.9%2 $506.27 1/15/20212,390,000 shares $1.24 billion +6.2%2.4%2.6 $517.91 12/31/20202,250,000 shares $1.08 billion +14.8%2.2%2.4 $478.30 12/15/20201,960,000 shares $980.74 million -8.0%1.9%1.9 $500.38 11/30/20202,130,000 shares $1.09 billion +6.0%2.1%2.2 $514.05 11/15/20202,010,000 shares $1.14 billion -7.4%2.0%2.1 $566.43 10/30/20202,170,000 shares $1.21 billion -6.9%2.1%2.4 $555.79 10/15/20202,330,000 shares $1.40 billion +13.7%2.3%2.7 $600.82 9/30/20202,050,000 shares $1.15 billion +28.1%2.0%2.4 $559.78 9/15/20201,600,000 shares $927.84 million +0.6%1.6%2.1 $579.90 8/31/20201,590,000 shares $985.69 million -0.6%1.6%2 $619.93Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report 8/14/20201,600,000 shares $980.11 million -15.3%1.6%1.4 $612.57 7/31/20201,890,000 shares $1.19 billion -5.0%1.9%1.5 $632.07 7/15/20201,990,000 shares $1.28 billion -6.1%1.9%1.5 $641.23 6/30/20202,120,000 shares $1.32 billion -14.2%2.0%1.5 $623.65 6/15/20202,470,000 shares $1.46 billion +24.1%2.3%1.7 $590.57 5/29/20201,990,000 shares $1.22 billion +11.8%1.9%1.3 $612.81 5/15/20201,780,000 shares $1.03 billion -4.8%2.1%1.2 $576.72 4/30/20201,870,000 shares $983.40 million -7.0%2.2%1.4 $525.88 4/15/20202,010,000 shares $1.03 billion +12.9%2.5%1.5 $511.69 3/31/20201,780,000 shares $1.01 billion -30.4%2.2%1.4 $566.21 3/13/20202,558,900 shares $1.31 billion -11.2%3.1%2 $512.96 2/28/20202,880,000 shares $1.31 billion +8.7%3.5%2.9 $455.63 2/14/20202,650,000 shares $1.26 billion -8.3%3.2%3 $475.02 1/31/20202,890,000 shares $1.32 billion +10.3%3.5%3.5 $457.92 1/15/20202,620,000 shares $1.04 billion +5.7%3.2%3.4 $396.75 12/31/20192,480,000 shares $856.29 million +0.8%3.0%3.4 $345.28 8/15/20192,351,800 shares $669.63 million -7.4%2.9%2.8 $284.73 REGN Short Interest - Frequently Asked Questions What is Regeneron Pharmaceuticals' current short interest? Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 1,630,000 shares of REGN short. Learn More on Regeneron Pharmaceuticals' current short interest. What is a good short interest ratio for Regeneron Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 4.0. Learn More on Regeneron Pharmaceuticals's short interest ratio. Which institutional investors are shorting Regeneron Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, PEAK6 Investments LLC, JPMorgan Chase & Co., Twin Tree Management LP, XR Securities LLC, SG Americas Securities LLC, Capstone Investment Advisors LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Covenant Asset Management LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Regeneron Pharmaceuticals' short interest increasing or decreasing? Regeneron Pharmaceuticals saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,630,000 shares, an increase of 3.8% from the previous total of 1,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Regeneron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Regeneron Pharmaceuticals: Vertex Pharmaceuticals Incorporated (1.46%), GSK plc (0.52%), Sanofi (0.16%), Bristol-Myers Squibb (1.39%), Zoetis Inc. (1.32%), Takeda Pharmaceutical Company Limited (0.21%), Abbott Laboratories (0.85%), Royalty Pharma plc (3.47%), BeiGene, Ltd. (1.75%), Catalent, Inc. (3.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Regeneron Pharmaceuticals stock? Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading down $6.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regeneron Pharmaceuticals? A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further. How often is Regeneron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VRTX Short Interest Data GSK Short Interest Data SNY Short Interest Data BMY Short Interest Data ZTS Short Interest Data TAK Short Interest Data ABT Short Interest Data RPRX Short Interest Data BGNE Short Interest Data CTLT Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REGN) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBitcoin’s Biggest Year YetParadigm PressWrite this ticker symbol down…StocksToTradeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.